|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||10.88 - 11.86|
|52 Week Range||5.50 - 15.00|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Puma Biotech (PBYI) falls more than 8% as it misses on both earnings and revenues in the third quarter of 2020. The company trims its 2020 revenue guidance for Nerlynx.
As you might know, Puma Biotechnology, Inc. (NASDAQ:PBYI) last week released its latest quarterly, and things did not...
PBYI earnings call for the period ending September 30, 2020.